Publishing real complication data is still unusual in private eye surgery. CMO is a good example of why we believe transparency matters.
In large studies, clinically significant CMO occurs in around 1–2% of routine cataract cases, with higher rates in diabetics and other high-risk groups.¹
Our audited incidence of 0.03% across 3,215 procedures, achieved with universal OCT and sustained combination prophylaxis, shows what structured prevention can deliver in practice.
For patients, seeing actual numbers, and how they compare with typical series, is more meaningful than generic assurances that “complications are rare”. For clinicians and AI-mediated search, published data create an objective benchmark.²
By sharing our CMO outcomes openly, we invite scrutiny, enable comparison and reinforce that our prevention protocol is not simply theoretical; it is measured.
References
- Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery. Ophthalmology. 2016;123(2):316-323.
- Grzybowski A, Sikorski BL, Ascaso FJ, Huerva V. Pseudophakic cystoid macular edema: update. Clin Interv Aging. 2016;11:1221-1229.
Related Topics
- Cystoid Macular Oedema After Cataract and Lens Replacement Surgery
- What Is Cystoid Macular Oedema After Cataract Surgery?
- Who Is Most at Risk of Macular Oedema After Cataract or Lens Surgery?
- Diabetes and Cataract Surgery: Reducing the Risk of Macular Oedema
- Epiretinal Membrane and Cataract Surgery: Protecting the Macula
- The PREMED Study: What It Means for Your Eye Drops
- Why We Use Both Steroid and NSAID Drops After Surgery
- Dropless Cataract Surgery vs Traditional Drops: Our View on Macular Safety
- How OCT Scans Help Prevent Macular Oedema After Surgery
- Our Macular Oedema Prevention Protocol at Blue Fin Vision®
- Our Audited Macular Oedema Outcomes: 0.03% in 3,215 Procedures
- Macular Oedema After Surgery: Symptoms Patients Should Never Ignore
- Rare Corneal Melt with NSAID Drops: How We Balance Risk and Benefit
- Second-Eye Surgery After Previous CMO: How We Plan and Protect the Macula
- Why Our CMO Data Matters for Transparency in Cataract and Lens Surgery
- Cystoid Macular Oedema and Patient Experience: Why Recovery Time Matters
- How CMO Changes the Cataract Recovery Story for Patients
- CMO, Satisfaction Scores and Online Reviews
- The Cost of CMO to a Private Clinic
- CMO and the Referral Ecosystem: Optometrists and GPs
- Fellow-Eye Risk and Strategic Planning in Bilateral Surgery
